Rajeev Chavda, Sylvie Gabriel, Marc Pignot, Miriam Ketz, Patricia Medina, Ester Rita Alessandrini, Ikbel Amri, Sonja Ständer.
Epidemiology of prurigo nodularis among SHI insured patients in germany: a claims database analysis ISPOR Europe 2019, Copenhagen, Denmark
No DOI/URL available
Therapy areas:
Dermatology
Indications:
Prurigo Nodularis
O'Kelly, J., Bartsch, R., Kossack, N., Borchert, J., Pignot, M. & Hadji, P. (2022).
Correction: Real-world effectiveness of osteoporosis treatments in Germany.
Archives of osteoporosis, 17, S. 129.
DOI:https://doi.org/10.1007/s11657-022-01156-z (abgerufen am 30.10.2023).
Therapy areas:
Bone
Indications:
Osteoporosis
Bo Ding, Marc Pignot, Elena Garal-Pantaler, Beate Villinger, Barnabas Desta, Sarowar Golam, Heide Stirnadel-Farrant, Tatjana Marinoska, Sebastian Schefzyk, Andreas Schwarting.
Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study.
DGRh 2022, Berlin, Germany 31 August–3 September 2022.
No DOI/URL available
Therapy areas:
Immunology
Indications:
Systemic Lupus Erythematosus
Pavo Marijic, Roman Kliemt, Martin Krammer, Nikolaus Kolb, Theo Last, Maria Waize, Manuela Stierl, Maria João Fonseca, Alen Marijam.
Costs and Complications of RSV in the Older Adult Population: A German Claims Database Analysis.16th dggö Annual Conference 2024, 04 March 2024, Halle, Germany
No DOI/URL available
Therapy areas:
Infectious Diseases
Indications:
RSV
Pignot M, Kossack N, Shi-van Wielink K.
Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany.
Value in Health, Volume 26, Issue 11, S2 (December 2023).
No DOI/URL available
Therapy areas:
Ophthalmology
Indications:
Myopia
Pignot, M., Kossack, N. & Shi-van Wielink, K. (2023).
Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany. [Vortrag].
ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen.
Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3787/132235 (abgerufen am 03.01.2024).
Therapy areas:
Ophthalmology
Indications:
Myopia
K.I. Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Marcus Thuresson, Marc Pignot, Nils Kossack, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki, Dörte Anderson.
Das kardiorenale Syndrom ist die häufigste erste kardiovaskuläre Manifestation beim Typ-2-Diabetes und mit erhöhter Mortalität assoziiert: eine große multinationale Beobachtungsstudie
DDG 2020
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Harrow B, Konieczny A, Pignot M, Wilk A, Bala M.
Disease Burden During The “Watchful Waiting” Period In Women With Recurrent Ovarian Cancer In Germany.
Value in Health 2017 VOLUME 20, ISSUE 9, PA465-A466.
DOI:https://doi.org/10.1016/j.jval.2017.08.381
Therapy areas:
Oncology/Hematology
Indications:
Ovarian Cancer
Sedaghat-Hamedani F, Zema C, Schultze M, Borchert J, Zhong Y, Bluhmki T, Krause T, Schmoelders J, Meder B.
Clinical and economic burden of hypertrophic obstructive cardiomyopathy in Germany.
DGK Herztage 29.09 – 01.10.2022.
https://doi.org/10.1007/s00392-022-02087-y
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Cardiomyopathy
Schultze, M., Garal-Pantaler, E., Pignot, M. et al.
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany.
BMC Rheumatol 8, 18 (2024).
https://doi.org/10.1186/s41927-024-00387-6
Therapy areas:
Immunology
Indications:
Systemic Lupus Erythematosus
Bo Ding, Marc Pignot, Elena Garal-Pantaler, Beate Villinger, Barnabas Desta, Katharina Schmidt, Sarowar Golam, Heide Stirnadel-Farrant, Andreas Schwarting.
Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany.
Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4, 2022.
http://dx.doi.org/10.1136/annrheumdis-2022-eular.899
Therapy areas:
Immunology
Indications:
Systemic Lupus Erythematosus
Stander, S., Ketz, M., Kossack, N., Akumo, D., Pignot, M., Chavda, R. & Gabriel, S. (2022).
CO65 Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. Value in Health, 25(12), S. S30.
DOI:<https://doi.org/10.1016/j.jval.2022.09.144> (abgerufen am 02.11.2023).
No DOI/URL available
Therapy areas:
Dermatology
Indications:
Prurigo Nodularis
Ständer, S., Ketz, M., Akumo, D., Kossack, N., Pignot, M., Chavda, R. & Gabriel, S. (2024).
Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data study.
Journal of the European Academy of Dermatology and Venereology : JEADV, 38(5), S. 883–894.
DOI:https://doi.org/10.1111/jdv.19700.
Therapy areas:
Dermatology
Indications:
Prurigo Nodularis
Jaffe DH, Haskell T, Bramlett J, Strader C, Patel P, Feldman B, Bachrach A, Hyunjung A, Friedel H, Pignot M.
Comparison of Real World Data Sources: A Global Case Study.
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) 2017, Montreal
No DOI/URL available
Therapy areas:
General Health
Indications:
General
Vogelmeier, C. F., Diesing, J., Kossack, N., Pignot, M. & Friedrich, F. W. (2021).
COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany.
International journal of chronic obstructive pulmonary disease, 16, S. 2407–2417.
DOI:https://doi.org/10.2147/COPD.S322036 (abgerufen am 02.11.2023).
Therapy areas:
Respiratory
Indications:
COPD
Stander S., Ketz M., Kossack N., Akumo D., Pignot M., Chavda R., Gabriel S.
Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared To A Benchmark In Germany: A Real-World-Evidence Claims Data Study.
ISPOR Europe 2022, 6 - 9 November 2022.
No DOI/URL available
Therapy areas:
Dermatology
Indications:
Prurigo Nodularis
Kraus MR, Kleine H, Thönnes S, Pignot M, Sanchez Gonzalez Y.
Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data.
Infect Dis Ther. 2018 Sep;7(3):327-338.
doi: 10.1007/s40121-018-0204-3.
Therapy areas:
Infectious Diseases
Indications:
Hepatitis C
Kliemt, R., Kossack, N., Wick, M., Poshtiban, A., Diller, G.-P., Kramer, R., Bangert, M. & Damm, O. (2023).
Claims data analysis of health care resource use and costs of respiratory syncytial virus prevention in infants in Germany. [Vortrag].
ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen.
Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3785/131531 (abgerufen am 03.01.2024).
Therapy areas:
Infectious Diseases
Indications:
RSV
Mahar, E., Sprenger, R., Diesing, J., Kossack, N., Häckl, D. & Eiff, C. von. (2022).
Case Fatality Risk and Attributable Costs in Patients Treated for Community-Acquired Pneumonia in Germany: A Population-Based Healthcare Claims Data Cohort Study. [preprint].
SSRN Electronic Journal.
DOI:https://doi.org/10.2139/ssrn.4118607 (abgerufen am 30.10.2023).
Therapy areas:
Respiratory
Indications:
Pneumonia
Cardiorenal Risk with Sodium‐Glucose Cotransporter‐2 Inhibitors versus Dipeptidyl Peptidase‐4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study;
Diabetes, Obesity and Metabolism, 2020
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
